The technical breakout I thought we might see in EXACT Sciences (Nasdaq:EXAS) is now in full gear.  EXACT shares are up about 70% since the last post, and over 300% off December lows.  Technically, part of the bounce is simply a matter of seller exhaustion.  But its a lot more than that. Since December,  EXACT [...]

Let me admit from the outset that I  hate investing in pharma and biotech.  I’m not a science guy, and the business model of many companies in these sectors perplexes me. That said, I have added EXACT Sciences (Nasdaq:EXAS) to my watch list.   According to the company, it “uses applied genomics to develop patient-friendly screening [...]